Stem Cell Research & Therapy

Scope & Guideline

Catalyzing Discoveries in Molecular Medicine

Introduction

Welcome to your portal for understanding Stem Cell Research & Therapy, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationSTEM CELL RES THER / Stem Cell Res. Ther.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

Stem Cell Research & Therapy focuses on advancing the understanding and application of stem cell biology in regenerative medicine and therapeutic interventions. The journal encompasses a wide range of topics related to stem cell research, including their mechanisms, applications, and the potential benefits they offer across various medical fields.
  1. Stem Cell Characterization and Mechanisms:
    Research articles often explore the biological characteristics, differentiation potential, and mechanisms of action of various types of stem cells, including mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs), and other progenitor cells.
  2. Therapeutic Applications of Stem Cells:
    The journal publishes studies on the clinical applications of stem cells in treating a variety of diseases and conditions, such as autoimmune disorders, cardiovascular diseases, and neurological conditions, emphasizing their potential in regenerative medicine.
  3. Extracellular Vesicles and Secretome:
    A significant focus is placed on the role of stem cell-derived extracellular vesicles and secretomes, highlighting their therapeutic potential in modulating immune responses, enhancing tissue repair, and their applications in drug delivery.
  4. Innovative Techniques in Stem Cell Research:
    The journal features advancements in methodologies for stem cell isolation, culture, and differentiation, including bioprinting, 3D culture systems, and genetic engineering techniques like CRISPR/Cas9.
  5. Interdisciplinary Approaches in Stem Cell Therapy:
    Research often integrates approaches from molecular biology, immunology, and bioengineering to address challenges in stem cell therapy, including issues related to cell survival, engraftment, and immune modulation.
The journal has increasingly focused on specific trending and emerging themes in stem cell research, reflecting advancements in technology, therapeutic applications, and interdisciplinary approaches. These themes are critical for future research directions and clinical applications.
  1. Regenerative Medicine and Tissue Engineering:
    There is a growing emphasis on the use of stem cells in regenerative medicine and tissue engineering, with numerous studies focusing on their ability to repair and regenerate damaged tissues and organs, particularly in orthopedic and cardiovascular applications.
  2. Stem Cell-Derived Exosomes and Their Therapeutics:
    Research on exosomes derived from stem cells is rapidly increasing, highlighting their potential as a cell-free therapeutic strategy for various diseases, including cancer, cardiovascular diseases, and neurodegenerative conditions.
  3. Immunomodulatory Properties of Stem Cells:
    The immunomodulatory effects of stem cells, especially in the context of inflammatory diseases and transplant rejection, are gaining attention, as studies explore how stem cells can modulate immune responses to enhance therapeutic outcomes.
  4. Personalized Stem Cell Therapies:
    There is a trend towards personalized approaches in stem cell therapies, including the use of patient-derived iPSCs to create tailored treatments for individual patients, particularly in genetic disorders and cancer.
  5. Stem Cell Therapy for COVID-19 and Other Acute Conditions:
    The journal has seen an increase in research focusing on the application of stem cell therapies in treating COVID-19 and other acute conditions, exploring their potential in immune modulation and tissue repair.

Declining or Waning

While Stem Cell Research & Therapy has seen a rise in various thematic areas, certain topics have shown a decline in publication frequency or relevance over recent years. These waning scopes may reflect shifting research priorities or advancements in alternative therapeutic approaches.
  1. Traditional Stem Cell Sources:
    There has been a noticeable decrease in studies focusing on traditional sources of stem cells, such as bone marrow and embryonic stem cells, as research increasingly shifts towards more versatile and ethically favorable sources, such as iPSCs and MSCs from various tissues.
  2. Basic Stem Cell Biology:
    Research that solely focuses on basic stem cell biology without direct clinical applications appears to be declining. The trend is moving towards more translational studies that emphasize therapeutic implications and clinical outcomes.
  3. End-of-Life Applications of Stem Cells:
    The exploration of stem cell therapies for end-of-life conditions has decreased, as the journal emphasizes more on regenerative applications and therapeutic interventions that can significantly improve patient outcomes.

Similar Journals

Current Stem Cell Research & Therapy

Advancing the Frontiers of Stem Cell Science
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1574-888XFrequency: 8 issues/year

Current Stem Cell Research & Therapy, published by Bentham Science Publishers Ltd, is a leading journal dedicated to advancing the field of stem cell research. With an ISSN of 1574-888X and an E-ISSN of 2212-3946, this journal has been a valuable resource since its inception in 2006 and continues to broaden its scope through 2024. Recognized in the Q2 quartile for Medicine (miscellaneous) and ranked in the 66th percentile among its peers, the journal plays a crucial role in disseminating high-quality, peer-reviewed research that explores both the therapeutic and biological implications of stem cells. Located in the United Arab Emirates, Current Stem Cell Research & Therapy embraces a global audience of researchers, professionals, and students, providing a vibrant platform for discourse and innovation. While the journal offers subscription-based access, it remains committed to enhancing the scientific community's understanding of stem cell therapy and its applications across various medical fields.

Cells

Exploring Innovative Pathways in Molecular Biology
Publisher: MDPIISSN: Frequency: 24 issues/year

Cells, published by MDPI in Switzerland, is a leading open-access journal that has been disseminating groundbreaking research in the fields of Biochemistry, Genetics, and Molecular Biology since its inception in 2011. With an impressive E-ISSN of 2073-4409, the journal boasts a strong impact factor and ranks in the 84th percentile for Scopus ratings, underscoring its significance in advancing scientific knowledge. As a Q1-ranked journal in both 2023 and 2020, it serves as a premier platform for researchers, professionals, and students eager to explore innovative findings and methodologies. By providing unrestricted access to high-quality research, Cells plays a pivotal role in facilitating collaboration and inspiration within the global scientific community, making it an indispensable resource for anyone interested in cutting-edge discoveries in cellular biology.

CYTOTHERAPY

Pioneering Innovations in Regenerative Medicine.
Publisher: ELSEVIER SCI LTDISSN: 1465-3249Frequency: 12 issues/year

CYTOTHERAPY is a distinguished journal published by Elsevier Science Ltd, focusing on the critical fields of cell therapy, transplantation, and regenerative medicine. Since its inception in 1999, the journal has established itself as a vital resource for researchers and practitioners, contributing significantly to advancements in Cancer Research, Cell Biology, Genetics, Immunology, and Oncology. With an impressive range of Q2 rankings across multiple categories and a remarkable Q1 standing in Transplantation for 2023, CYTOTHERAPY delivers high-impact research that addresses the evolving challenges in these fields. While the journal does not offer open access, it remains a reputable avenue for disseminating pivotal studies and reviews that push the boundaries of cell-based therapies. Researchers, clinicians, and students alike will find CYTOTHERAPY an indispensable platform to stay abreast of the latest discoveries and innovations that are shaping the future of medical science.

Regenerative Therapy

Advancing regenerative medicine through open access innovation.
Publisher: ELSEVIERISSN: 2352-3204Frequency:

Regenerative Therapy is a premier open-access journal dedicated to advancing the fields of biomaterials, biomedical engineering, and developmental biology. Published by Elsevier in Japan, this journal has been an influential platform since its inception in 2015, contributing significantly to the global discourse on regenerative medicine. With an impressive Q2 ranking in major categories such as Biomaterials and Biomedical Engineering, it is recognized for its quality of research and innovation. Researchers seeking to disseminate their findings or explore cutting-edge developments will find Regenerative Therapy to be invaluable, reflecting current trends and fostering collaborations across interdisciplinary boundaries. The journal offers open access, ensuring that high-quality research is available to a broad audience and enhances the impact of scholarly work in the regenerative medicine community.

Cell Journal

Fostering Global Collaboration in Cell Research
Publisher: ROYAN INSTISSN: 2228-5806Frequency: 12 issues/year

Cell Journal is a leading interdisciplinary publication in the fields of Cell Biology, Developmental Biology, Molecular Biology, and Reproductive Medicine, published by ROYAN INST since its inception as an open-access journal in 2007. With an ISSN of 2228-5806 for print and 2228-5814 for electronic editions, it provides a vital platform for researchers and professionals to disseminate innovative findings and insights that shape our understanding of cellular processes and reproductive sciences. The journal boasts an impressive Scopus ranking, achieving a Q3 position in both Molecular Biology and Reproductive Medicine, highlighting its significance in the academic community. Situated in Tehran, Iran, Cell Journal encourages global collaboration through its accessible content, making cutting-edge research available to a diverse audience. As it converges from 2011 to 2024, the journal continues to emphasize the importance of thorough scientific inquiry, fostering advancements that drive both theoretical frameworks and practical applications in cell science.

Cell Stem Cell

Exploring Breakthroughs that Shape the Future of Regenerative Medicine
Publisher: CELL PRESSISSN: 1934-5909Frequency: 12 issues/year

Cell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.

Stem Cell Research

Empowering the future of medical science.
Publisher: ELSEVIERISSN: 1873-5061Frequency: 6 issues/year

Stem Cell Research is a premier Open Access journal published by ELSEVIER, dedicated to advancing the understanding of stem cell biology. Since its inception in 2007, the journal has provided a platform for the latest research in the fields of Cell Biology, Developmental Biology, and Medicine, with its publication being accessible globally since 2014. Located in the Netherlands, the journal’s comprehensive scope aims to bridge fundamental discoveries with clinical applications, fostering collaboration among researchers and professionals. With a 2023 impact factor reflected in its Q4 ranking in Cell and Developmental Biology and a commendable position in the 64th percentile for General Medicine, Stem Cell Research remains a vital resource for those interested in the dynamic landscape of regenerative medicine. Targeting an audience that includes researchers, practitioners, and students, the journal emphasizes not only the significance of stem cells in medical science but also the ethical considerations and the public discourse surrounding stem cell research. Join the community committed to pioneering the future of stem cell science through rigorous peer-reviewed research.

Journal of Tissue Engineering and Regenerative Medicine

Bridging engineering and medicine for transformative health.
Publisher: WILEYISSN: 1932-6254Frequency: 12 issues/year

Journal of Tissue Engineering and Regenerative Medicine, published by WILEY, stands as a pivotal platform in the fields of biomaterials, biomedical engineering, and regenerative medicine. With an ISSN of 1932-6254 and an E-ISSN of 1932-7005, this journal, based in the United Kingdom, has consistently delivered high-quality research since its inception in 2006, converging critical insights through 2024. With an impressive citation profile reflected in its Scopus rankings—specifically a rank of #58 in Medicine and #75 in Biomedical Engineering—the journal is acknowledged for its substantial impact, as demonstrated by its competitive quartile standings in 2023. Notably, it maintains a Q3 ranking in Biomaterials and Q2 in both Biomedical Engineering and Medicine (miscellaneous), showcasing its influence and relevance in the rapidly evolving interplay between engineering and medicine. The journal serves as a vital resource for researchers and practitioners aiming to stay abreast of innovations and breakthroughs in regenerative therapies, tissue scaffolds, and biomaterials. While not an open-access publication, it fosters academic dialogue and knowledge dissemination that is crucial for advancing the field.

Current Stem Cell Reports

Advancing the Frontiers of Stem Cell Science
Publisher: SPRINGER HEIDELBERGISSN: Frequency: 4 issues/year

Current Stem Cell Reports, published by Springer Heidelberg, is an esteemed academic journal that has emerged as a pivotal resource in the fields of Cell Biology, Developmental Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has consistently contributed to the evolving discourse on stem cell research and its applications, providing a platform for innovative studies and reviews through 2024. With a notable impact indicated by its quartile rankings—Q2 in Developmental Biology and Genetics, and Q3 in Cell Biology and Molecular Biology—it engages a diverse audience of researchers, professionals, and students who seek high-quality, accessible research insights. Although offering a traditional access model, the content remains vital for those invested in understanding the implications of stem cell advancements. Located in Switzerland and operating from the heart of Heidelberg, this journal aspires to bridge gaps in knowledge and stimulate collaboration in the burgeoning field of stem cell science.

Inflammation and Regeneration

Empowering discoveries in inflammation and regenerative therapies.
Publisher: BMCISSN: Frequency: 1 issue/year

Inflammation and Regeneration is a prominent open-access journal published by BMC, focused on the discerning fields of immunology, cell biology, and regenerative medicine. Since its establishment in 2016, the journal has provided a platform for the dissemination of high-quality research, contributing significantly to the advancement of knowledge in inflammation processes and regenerative therapies. With a remarkable impact reflected in its Q1 quartile rankings in Cell Biology and Immunology for 2023, Inflammation and Regeneration stands out as a leading resource for researchers and practitioners. The journal's commitment to open access ensures that critical findings are readily available to a global audience, fostering collaboration and innovation in the scientific community. With a Scopus ranking that places it in the top 20% of its categories, Inflammation and Regeneration serves as an essential reference for those seeking to stay at the forefront of immunological research and its applications.